Immuneering Corp
IMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001790340
No open-market purchases or sales by Immuneering Corp insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $171.6M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Immuneering Corp changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 96 | 111 | +15 |
| Shares | 29.3M | 34.4M | +5.13M (+17.5%) |
| Value | $154.3M | $171.6M | +$17.3M (+11.2%) |
New holders (37)
Institutions that held Immuneering Corp at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (22)
Institutions that held Immuneering Corp at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Diametric Capital, LP | 174,897 | $921.7K |
| Wellington Management Group LLP | 156,424 | $824.4K |
| 683 Capital Management, LLC | 150,697 | $794.2K |
| Hudson Bay Capital Management LP | 95,889 | $505.3K |
| Weiss Asset Management LP | 87,985 | $463.7K |
| Brevan Howard Capital Management LP | 86,236 | $454.5K |
| Jane Street Group, LLC | 77,414 | $408.0K |
| Renaissance Technologies LLC | 72,875 | $384.1K |
| Landscape Capital Management, L.L.C. | 67,495 | $355.7K |
| HRT Financial LP | 42,456 | $223.0K |
| HSBC Holdings PLC | 37,771 | $197.5K |
| Prelude Capital Management, LLC | 29,219 | $154.0K |
| Omers Administration Corp | 22,400 | $118.0K |
| The PNC Financial Services Group, Inc. | 20,000 | $105.4K |
| Schonfeld Strategic Advisors LLC | 15,900 | $83.8K |
| Y-Intercept (Hong Kong) Ltd | 14,280 | $75.3K |
| Catalyst Funds Management Pty Ltd | 12,800 | $67.5K |
| Atria Investments LLC | 10,758 | $56.7K |
| Caitong International Asset Management Co., Ltd | 9,151 | $48.2K |
| Simplex Trading, LLC | 8,942 | $47.1K |
| Natixis | 380 | $2.00K |
| Fortitude Family Office, LLC | 105 | $553 |